BECTON, DICKINSON AND COMPANY (BDX) FY2025 Annual P&L / Income Statement

Revenue by Business Segment

2024-10-01 to 2025-09-30

Swipe to see the full flow
BECTON, DICKINSON AND COMPANY (BDX) FY2025 Annual P&L / Income StatementIncome statement for 2024-10-01 through 2025-09-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.SOURCESREVENUEGROSSOPERATINGPRE-TAXNETMedicalInterventionalLife SciencesRevenuesGross profit (calculated)Cost of products soldOperating IncomeOperating expenses (calculated)Income from Continuing Operations Before Income TaxesOther income (expense), net (calculated)Net IncomeIncome tax provisionIncome from Continuing Operations Before Income TaxesIncome from ContinuingOperations BeforeIncome Taxes$1.88 BGross profit (calculated)Gross profit(calculated)$9.93 BRevenuesRevenues$21.84 BOperating IncomeOperating Income$2.58 BNet IncomeNet Income$1.68 BOperating expenses (calculated)Operating expenses(calculated)$7.35 BMedicalMedical$11.46 BIncome tax provisionIncome taxes$203.00 MOther income (expense), net (calculated)Other income,net (calculated)−$698.00 MCost of products soldCost of products sold$11.92 BInterventionalInterventional$5.22 BLife SciencesLife Sciences$5.17 B
Chart details

BECTON, DICKINSON AND COMPANY (BDX) FY2025 Annual P&L / Income Statement

Income statement for 2024-10-01 through 2025-09-30. View: Business segment. Revenue uses this breakdown; costs and expenses retain the consolidated categories.

Revenues
21,840,000,000 US dollars
Cost of products sold
11,915,000,000 US dollars
Gross profit (calculated)
9,925,000,000 US dollars
Operating expenses (calculated)
7,346,000,000 US dollars
Operating Income
2,579,000,000 US dollars
Other income (expense), net (calculated)
negative 698,000,000 US dollars
Income from Continuing Operations Before Income Taxes
1,881,000,000 US dollars
Income tax provision
203,000,000 US dollars
Net Income
1,678,000,000 US dollars
Medical
11,456,000,000 US dollars
Life Sciences
5,167,000,000 US dollars
Interventional
5,217,000,000 US dollars
Selling and administrative expense
5,278,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Research and development expense
1,265,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Integration, restructuring and transaction expense
408,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Other operating expense (income), net
396,000,000 US dollars. Source detail retained; this breakdown has not reconciled exactly and is not drawn.
Loss from Discontinued Operations, Net of Tax
0 US dollars. Reported below-tax contribution to net income.
Medical costs (calculated)
7,316,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Life Sciences costs (calculated)
3,526,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Interventional costs (calculated)
2,964,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.
Reconciling items (calculated)
5,455,000,000 US dollars. Segment revenue less segment operating income; it includes cost of revenue and operating expenses.

Chart connections

  • Revenue less cost of revenue equals gross profit; gross profit less operating expenses equals operating income.
  • Operating income plus other income or expense equals income before tax. Income before tax less income tax expense or benefit, plus the explicitly reported below-tax contributions, equals net income.
BECTON, DICKINSON AND COMPANY (BDX) FY2025 Annual P&L / Income Statement Sankey chart, Business segment view
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Gross margin

45.4%

Gross profit / revenue

Operating margin

11.8%

Operating profit / revenue

Cash conversion

204.4%

Operating cash / net income, same period

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!